SLN

Silence Therapeutics
SLN

Overview Fund Activity

6 hedge funds and large institutions have $55.9M invested in Silence Therapeutics in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
4
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
1
BVF Inc
California
$15.8M
2
LOAMU
2
Lombard Odier Asset Management (USA)
New York
$24.4M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$10.2M
4
CCM
4
Consonance Capital Management
New York
$5.11M
5
Morgan Stanley
5
Morgan Stanley
New York
$233K

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
LOAMU
1
Lombard Odier Asset Management (USA)
New York
$24.4M 1,198,141 +658,141 +122%
BI
2
BVF Inc
California
$15.8M 666,666 +666,666 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$10.2M 444,444 +444,444 New
CCM
4
Consonance Capital Management
New York
$5.11M 222,222 +222,222 New
Morgan Stanley
5
Morgan Stanley
New York
$233K 10,118 +8,118 +406%
SG Americas Securities
6
SG Americas Securities
New York
$129K 5,445 +5,445 New
UBS Group
7
UBS Group
Switzerland
– – -93 Closed
CFGS
8
Concourse Financial Group Securities
Alabama
– – – –